HSPA5 and non-small cell lung carcinoma: Consistent with observations in gefitinib-resistant HCC827 NSCLC cells [21], this study further demonstrated CHOP induction along with GRP78 suppression by the Se-Y and FO combination in cisplatin-resistant A549 sphere cells.